Shanxi Zhendong Pharmaceutical (300158) — Cash Flow-to-Debt Ratio
Shanxi Zhendong Pharmaceutical (300158) has a Cash Flow-to-Debt Ratio of -0.22x as of September 2025, meaning its operating cash flow of CN¥-197.94 Million could theoretically repay 0% of its total liabilities (CN¥882.65 Million) in one year. Explore how much of Shanxi Zhendong Pharmaceutical's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanxi Zhendong Pharmaceutical Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Shanxi Zhendong Pharmaceutical across 18 annual periods. Also explore Shanxi Zhendong Pharmaceutical balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shanxi Zhendong Pharmaceutical (2007–2024)
Year-by-year debt coverage analysis for Shanxi Zhendong Pharmaceutical. For market capitalisation and broader financial context, see Shanxi Zhendong Pharmaceutical stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.11x | CN¥-149.82 Million | CN¥1.32 Billion | ▲ +38.2% |
| 2023 | -0.18x | CN¥-189.95 Million | CN¥1.04 Billion | ▼ -381.9% |
| 2022 | 0.07x | CN¥86.31 Million | CN¥1.33 Billion | ▼ -53.4% |
| 2021 | 0.14x | CN¥284.45 Million | CN¥2.04 Billion | ▲ +23.8% |
| 2020 | 0.11x | CN¥221.94 Million | CN¥1.97 Billion | ▼ -10.9% |
| 2019 | 0.13x | CN¥186.35 Million | CN¥1.47 Billion | ▲ +51.4% |
| 2018 | 0.08x | CN¥154.48 Million | CN¥1.85 Billion | ▲ +280.7% |
| 2017 | 0.02x | CN¥45.09 Million | CN¥2.06 Billion | ▲ +178.6% |
| 2016 | -0.03x | CN¥-44.72 Million | CN¥1.60 Billion | ▼ -137.5% |
| 2015 | 0.07x | CN¥151.84 Million | CN¥2.04 Billion | ▼ -9.7% |
| 2014 | 0.08x | CN¥73.23 Million | CN¥888.23 Million | ▲ +192.1% |
| 2013 | -0.09x | CN¥-75.04 Million | CN¥838.64 Million | ▼ -132.3% |
| 2012 | 0.28x | CN¥189.40 Million | CN¥684.26 Million | ▲ +224.0% |
| 2011 | -0.22x | CN¥-88.73 Million | CN¥397.40 Million | ▼ -368.2% |
| 2010 | 0.08x | CN¥32.40 Million | CN¥389.13 Million | ▼ -44.1% |
| 2009 | 0.15x | CN¥42.28 Million | CN¥283.87 Million | ▲ +3.2% |
| 2008 | 0.14x | CN¥33.18 Million | CN¥229.98 Million | ▼ -67.4% |
| 2007 | 0.44x | CN¥128.65 Million | CN¥290.28 Million | — |